share_log

HC Wainwright & Co. Reiterates Buy on Milestone Pharmaceuticals, Maintains $25 Price Target

HC Wainwright & Co. Reiterates Buy on Milestone Pharmaceuticals, Maintains $25 Price Target

HC Wainwright & Co.重申買入Milestone Pharmicals,維持25美元的目標
Benzinga ·  2023/08/14 11:08

HC Wainwright & Co. analyst Patrick Trucchio reiterates Milestone Pharmaceuticals (NASDAQ:MIST) with a Buy and maintains $25 price target.

HC Wainwright&Co.分析師帕特裡克·楚奇奧重申了里程碑製藥(納斯達克:MIST)的買入,並維持25美元的目標價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論